Article Information
History
- April 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Cameron Mura1,†,*,
- Saskia Preissner2,†,*,
- Susanne Nahles2,
- Max Heiland2,
- Philip E. Bourne1 and
- Robert Preissner3
- 1School of Data Science and Department of Biomedical Engineering, University of Virginia, Charlottesville, VA; USA
- 2Department Oral and Maxillofacial Surgery, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353 Berlin, Germany
- 3Institute of Physiology and Science-IT, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Philippstrasse 12, 10115 Berlin, Germany
- ↵*Correspondence can be addressed to SP (Saskia.Preissner{at}charite.de) or CM (cmura{at}virginia.edu).
↵† Equally contributing authors
Author contributions Conception and design: SP and RP
Acquisition, analysis and interpretation of data: SP, RP, CM, PEB, SN, MH
Drafting of the manuscript: CM, SP, RP, PEB
Supervision: RP, PEB
Critical revision of the manuscript: CM, RP, PEB
Final approval: all authors
Posted April 05, 2021.
Clinical Evidence for Improved Outcomes with Histamine Antagonists and Aspirin in 22,560 COVID-19 Patients
